Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Premium Newsletters
Smart Value
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
KNSA
Stock Latest News
The Fly
Kiniksa initiated with a Buy at Citi
15d ago
KNSA
Premium
Company Announcements
Kiniksa Pharmaceuticals Reports Strong Growth Amid Challenges
28d ago
KNSA
Premium
The Fly
Kiniksa price target lowered to $30 from $35 at Wells Fargo
30d ago
KNSA
Premium
Ratings
Buy Rating for Kiniksa Pharmaceuticals Driven by Strategic Refocus and Commercial Success
30d ago
KNSA
Premium
Ratings
Kiniksa Pharmaceuticals: Strategic Focus on Cardiovascular Growth and Stability Underpins Buy Rating
30d ago
KNSA
Premium
Company Announcements
Kiniksa Pharmaceuticals Reports Strong ARCALYST Growth
1M ago
KNSA
Premium
Company Announcements
Kiniksa Pharmaceuticals Ends License Agreement with MedImmune
1M ago
8K
KNSA
Premium
The Fly
Kiniksa reports Q4 EPS (12c), consensus 13c
1M ago
KNSA
Premium
The Fly
Kiniksa sees FY25 ARCALYST net product revenue $560M-$580M
1M ago
KNSA
Premium
The Fly
Kiniksa announces development of KPL-387, updated corporate strategy
1M ago
KNSA
Premium
The Fly
Kiniksa to discontinue development of abiprubart in Sjogren’s Disease
1M ago
KNSA
Premium
Pre-Earnings
Kiniksa Pharmaceuticals Ltd. Class A (KNSA) Q4 Earnings Cheat Sheet
1M ago
KNSA
Premium
The Fly
Kiniksa reports preliminary Q4 ARCALYST net product revenue $121.9M
2M ago
KNSA
Premium
The Fly
Short Report: CompoSecure shorts at multi-month lows
3M ago
IEP
CMPO
Premium
Market News
Kiniksa Pharmaceuticals (KNSA) Stock Drops 17%, Presenting a Potential Opportunity
5M ago
KNSA
Premium
Company Announcements
Kiniksa Pharmaceuticals Faces Financial Risks from Global Currency Fluctuations
5M ago
KNSA
Premium
Company Announcements
Kiniksa Pharmaceuticals Reports Strong Q3 2024 Growth
5M ago
KNSA
Premium
The Fly
Kiniksa Pharmaceuticals trading resumes
5M ago
KNSA
Premium
The Fly
Kiniksa Pharmaceuticals trading halted, volatility trading pause
5M ago
KNSA
Premium
The Fly
Kiniksa sees FY24 ARCALYST revenue between $410M-$420M
5M ago
KNSA
Premium
The Fly
Kiniksa reports Q3 EPS (18c), consensus 3c
5M ago
KNSA
Premium
The Fly
Kiniksa partners with Carly Pearce in expansion of Life DisRPted campaign
5M ago
KNSA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.